Clinical Trial

Salivary Angiotensin-Converting Enzyme and Periodontal Disease in Cardiovascular Disease

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn whether the renin-angiotensin system, measured by angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE2) in saliva and blood, is associated with periodontal disease severity in adults undergoing cardiovascular evaluation. The main questions it aims to answer are: * Are salivary and blood ACE and ACE2 levels different according to periodontal disease severity? * Do salivary ACE and ACE2 levels reflect the corresponding blood levels? * Are ACE and ACE2 levels related to clinical measures of periodontal disease? Participants will: * Complete medical and dental history assessments. * Undergo a comprehensive periodontal examination, including measurements of plaque, gingival inflammation, bleeding on probing, probing pocket depth, clinical attachment loss, and the number of remaining teeth. * Provide saliva and blood samples for laboratory measurement of ACE and ACE2.
Trial Details
NCT Number NCT07721428
Lead Sponsor Suleyman Demirel University
Conditions Periodontal Disease, Cardiovascular Disease
Enrollment 76 participants
Start Date 2021-03-01
Primary Completion 2021-06-12 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-23